Cantel Medical (NYSE: CMD) reported Q2 EPS of $0.57, $0.05 worse than the analyst estimate of $0.62. Revenue for the quarter came in at $224.5 million versus the consensus estimate of $226.95 million.

For earnings history and earnings-related data on Cantel Medical (CMD) click here.